Skip to main content

Drugs Made In America Acquisition Corp.

DMAA
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.

Other share classesDMAARDMAAU

13F holders, Q1 2026

Institutional positions in Drugs Made In America Acquisition Corp. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
0 vs. Q4 2025
Shares held
22.9M
+229.2K (+1.0%) vs. Q4 2025
Total value
$237.3M
+$5.27M (+2.3%) vs. Q4 2025
New holders
6
7 more added
Sold out
6
7 more reduced

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 39 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 24 institutionsQ2 2025: 32 institutionsQ3 2025: 37 institutionsQ4 2025: 39 institutionsQ1 2026: 39 institutionsQ2 2026: 23 institutions
Value heldQ1 2026: $237.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $171.3MQ2 2025: $212.3MQ3 2025: $223.4MQ4 2025: $232.1MQ1 2026: $237.3MQ2 2026: $124.9M
Institutions holding DMAA and their total value by quarter
QuarterHoldersValue
Q2 202623$124.9M
Q1 202639$237.3M
Q4 202539$232.1M
Q3 202537$223.4M
Q2 202532$212.3M
Q1 202524$171.3M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q4 2025.

Institutions holding DMAA in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Karpus Management, Inc.2,530,517$26.5M0.83%−8,125−0.3%Reduced
Vivaldi Asset Management, LLC2,242,500$23.5M1.23%00.0%Unchanged
Mizuho Securities USA LLC2,000,000$20.9M0.49%+566,517+39.5%Added
Glazer Capital, LLC1,678,406$17.6M0.37%−138,022−7.6%Reduced
Westchester Capital Management, LLC1,669,000$17.5M0.85%00.0%Unchanged
Polar Asset Management Partners Inc.1,600,000$16.8M0.40%00.0%Unchanged
Wolverine Asset Management LLC1,553,708$16.3M0.25%+246,240+18.8%Added
Highbridge Capital Management LLC1,323,351$13.9M0.88%+1,323,351New
Aristeia Capital LLC881,716$9.24M0.21%00.0%Unchanged
D. E. Shaw & Co., Inc.690,000$7.25M0.01%00.0%Unchanged
Heights Capital Management, Inc650,000$6.83M1.91%00.0%Unchanged
Shaolin Capital Management LLC550,000$5.76M0.24%+347,931+172.2%Added
Radcliffe Capital Management, L.P.546,808$5.74M0.43%00.0%Unchanged
LMR Partners LLP500,000$5.24M0.05%00.0%Unchanged
Rivernorth Capital Management, LLC417,998$4.38M0.22%00.0%Unchanged
Whitebox Advisors LLC400,000$4.19M0.06%00.0%Unchanged
Meteora Capital, LLC380,299$3.99M0.29%+380,299New
CNH Partners LLC357,585$3.75M0.06%−13,626−3.7%Reduced
RLH Capital LLC316,551$3.32M1.69%+316,551New
Hudson Bay Capital Management LP297,833$3.13M0.02%−1,252,167−80.8%Reduced
Quarry LP266,551$2.80M0.56%00.0%Unchanged
Governors Lane LP250,000$2.62M0.33%00.0%Unchanged
Context Capital Management, LLC250,000$2.62M0.06%00.0%Unchanged
Toronto Dominion Bank203,838$2.14M0.00%+3,838+1.9%Added
L1 Global Manager Pty Ltd200,000$2.10M1.69%00.0%Unchanged
Sona Asset Management (US) LLC162,795$1.71M0.07%+162,795New
Clear Street Group Inc.354,048$1.30M0.01%+28,075+8.6%Added
Goldman Sachs Group Inc119,686$1.25M0.00%00.0%Unchanged
DLD Asset Management, LP100,559$1.05M0.11%00.0%Unchanged
Warberg Asset Management LLC92,054$966.1K0.28%−10.0%Reduced
Geode Capital Management, LLC62,273$653.9K0.00%+16,625+36.4%Added
Periscope Capital Inc.50,000$524.8K0.09%00.0%Unchanged
JPMorgan Chase & Co49,881$523.3K0.00%+60+0.1%Added
Dakota Wealth Management36,400$381.5K0.01%00.0%Unchanged
Lineage Point Capital LP31,840$334.2K0.08%00.0%Unchanged
HRT Financial LP27,487$288.0K0.00%−795−2.8%Reduced
BNP Paribas Arbitrage, SA14,737$154.4K0.00%+14,737New
Citadel Advisors LLC10,476$110.0K0.00%+10,476New
Morgan Stanley58$6080.00%−63−52.1%Reduced
Mercuria Capital Strategies, LLC0$00.00%−750,000−100.0%Sold out
J. Goldman & Co LP0$00.00%−500,000−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−346,154−100.0%Sold out
Bulldog Investors, LLP0$00.00%−130,264−100.0%Sold out
UBS Group AG0$00.00%−38,159−100.0%Sold out
Logan Stone Capital, LLC0$00.00%−10,900−100.0%Sold out